Xuedong Wang1, Ailian Liu1, Jiazheng Wang2, Yishi Wang2, Anliang Chen1, Lihua Chen1, and Qingwei Song1
1The first affiliated hospital of dalian medical university, DaLian, China, 2Philips Healthcare, China, Beijing, China
Synopsis
The purpose of
this study was to investigate the feasibility of using APTw for the diagnosis of
rectal cancer.
Introduction
Rectal cancer is the third most common cancer and the second leading cause
of cancer-related death worldwide[1].Amide proton transfer-weighted imaging is
one subset of the endogenous chemical exchange saturation transfer (CEST)
imaging and magnetization transfer (MT) techniques. It can assess the changes
in the intracellular protein concentration and PH by detecting the proton
exchange between the amide protons in endogenous mobile proteins and bulk-water
protons.Amide proton transfer-weighted (APTw) imaging is well applied in head、breast and recta ldiseases[2-4]. The purpose of this study was to
investigate the feasibility of using APT for the diagnosis of rectal cancer.Methods
Seventeen patients with rectal cancer confirmed by postoperative
pathology and fourteen volunteers were enrolled in this retrospective study.
All subjects underwent 3.0T MR scan (Ingenia 3.0T CX; Philips Healthcare, Best,
the Netherlands) with a 16-channel abdominal array coil. Scanning sequences:
axial T2-weighted imaging (T2WI), 3D-amide proton transfer weighted
imaging (3D-APT) and diffusion weighted imaging (DWI). The scan parameters
were: T2WI, TR/TE= 4900/85ms, FOV=240 x 240 x 119mm3, voxel size 0.7x0.7x4mm3, scan time=2min48s.APT, TR/TE= 6500/8ms, FOV=130 x100 x49mm3, voxel size 2.0x2.0 x7mm3, scan time=3min3 s. DWI:TR/TE= 3900/60ms, FOV=240x240x119mm3, voxel size 3.0x3.0x4mm3,
scan time=1min46s. All data were
transferred to the IntelliSpace Portal, (Philips Healthcare). Two physicians
with 3 years and 6 years experience with MRI diagnosis were employed to draw3
ROIs respectively in the signal homogenization area of rectal cancer wall on
the DWI imaging and normal intestinal wall on the T2WI imaging, then getting
APTw fusion graph and APTw value(Figure 1).
The ROI value of the senior physician was taken as statistical analysis. The
average ROI for 3 times was taken as statistical analysis. Intra-group correlation coefficient (ICC) was used to test the
consistency of the measurement results of the two observers. The
difference of the parameters between the two groups, the data which obeys
normal distribution were performed by independent- samples T test, otherwise by
Mann-Whitney test. Finally, independent-sample t test was used to test the
difference between them. The ROC curve was applied to evaluate effectiveness of
statistically significant parameters in the differential diagnosis of two groups.Results
The consistency of data measured by two
observers was good (ICC>0.75)( Table 1).APTw value of rectal
cancer was higher than that of normal intestinal wall group, their values were2.71±0.68% vs 1.55±0.68% with a statistically significant difference(P<0.05)(
Table 2). The AUC was 0.878, and the corresponding diagnostic
sensitivity and specificity were 94.1% and 71.4%, respectively with the APTw =
1.83 as the cut-off value(Figure2).Discussion and Conclusion
In this study, the result showed that APTw value of rectal cancer is larger than that of
volunteer group. The reason may be that rectal
cancer is more protein-rich.APTw imaging may
serve as a preoperative and non-invasive method for the diagnosis of rectal
cancer wall.Acknowledgements
No
acknowledgment found. References
[1] Siegel
RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017[J]. Ca A Cancer Journal for Clinicians (2017)
67(3):104-117.
[2] Togao
O, Hiwatashi A, Keupp J, et al. Scan-rescan reproducibility of parallel transmission
based amide proton transfer imaging of brain tumors[J]. Magn Reson Imaging,
2015,42(5):1346-53.
[3] Dula AN, Arlinghaus LR, Dortch RD, et al. Amide
proton transfer imaging of the breast at 3 T: establishing reproducibility and
possible feasibility assessing chemotherapy response[J].Magn Reson Med,
2013,70(1):216-24.
[4]Nishie A, Asayama Y, Ishigami K,et al.Amide proton transfer imaging to predict tumor response
to neoadjuvant chemotherapy in locally advanced rectal cancer[J].J Gastroenterol Hepatol, 2019 Jan;34(1):140-146.